Are you or someone you know currently pregnant and taking opioids? Methadone, buprenorphine, or other daily pain medication?
Currently, there is not enough research to figure out how opioids affect the NOWS treatment weaning, diagnosis and severity of NOWS in infants. Women & Infants Hospital wants to understand how prenatal opioid exposure affects infants and if certain factors influence their development.
- Child and Family Study (CAFS):
Researchers at Women and Infants Hospital are looking to better understand infant development at 6 and 18 months related to Neonatal Opioid Withdrawal Syndrome (NOWS).
This study is open to pregnant moms 18-39 years old, who currently use or have used opioid drug(s) or medication(s) during pregnancy. Additional eligibility criteria are determined after the birth of your infant.
Participants will be paid a total of $225 in gift cards split up between each visit.
Interested in participating? To learn more about the study and speak with a member of the research team, please call (401) 680-6019 or email email@example.com
- Weaning Study: Neonatal Opioid Withdrawal Syndrome (NOWS)
Women & Infants Hospital, is participating with many other hospitals across the country in a clinical research study to learn about the best way to wean babies off of medicines used to treat NOWS. This study is called the Weaning Study. The goal of the Weaning Study is to improve the treatment and health of babies born with NOWS.
Participants will be paid a total of $350 over the course of the study for their time and cooperation.
Interested in participating? To learn more about the study and speak with a member of the research team, please call (401) 274-1122, ext. 4740. or email firstname.lastname@example.org.